Hellgren, K., Ballegaard, C., Delcoigne, B., Cordtz, R., Nordström, D., Aaltonen, K., . . . 1Clinical Epidemiology Division, D. o. M. S. (2022). Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study. Rheumatology, 60(8), 3656.
Chicago Style (17th ed.) CitationHellgren, Karin, et al. "Risk of Solid Cancers Overall and by Subtypes in Patients with Psoriatic Arthritis Treated with TNF Inhibitors - a Nordic Cohort Study." Rheumatology 60, no. 8 (2022): 3656.
MLA (9th ed.) CitationHellgren, Karin, et al. "Risk of Solid Cancers Overall and by Subtypes in Patients with Psoriatic Arthritis Treated with TNF Inhibitors - a Nordic Cohort Study." Rheumatology, vol. 60, no. 8, 2022, p. 3656.
Warning: These citations may not always be 100% accurate.